Home Data Calendar Blog

IONS

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Common Stock Value 0.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.120.120.120.120.120.120.120.120.120.120.120.12NA0.120.120.120.120.120.120.120.110.100.100.100.100.100.100.100.100.100.10NANANA
Weighted Average Number Of Diluted Shares Outstanding 141.95141.79141.60160.34141.14140.96140.77NA139.71139.35139.43153.30143.41140.25141.54149.86143.31128.71125.33126.86124.37123.99124.97123.95123.38120.80120.60NA119.98127.78NANA122.84NA117.59NANA115.26108.54101.88NA100.68100.21100.16NA99.6999.6099.57NA99.2099.0999.01
Weighted Average Number Of Shares Outstanding Basic 141.95141.79141.60141.21141.14140.96140.77139.96139.71139.35139.43140.58140.55140.25138.58137.70143.31128.71125.33124.82124.37123.99122.86121.34120.99120.80120.60NA119.98119.74NANA118.22NA117.59NANA115.26108.54101.88NA100.68100.21100.16NA99.6999.6099.57NA99.2099.0999.01
Earnings Per Share Basic -0.33-0.74-0.461.59-0.58-0.57-0.64-2.44-0.22-0.23-0.351.310.19-0.010.632.32-0.03-0.29-0.010.020.00-0.090.030.210.06-0.47-0.52-0.59-0.300.30NA-0.140.26-0.23-0.10-0.27NANANANANANANANA-0.20-0.27-0.18-0.20-0.14-0.13-0.25-0.10
Earnings Per Share Diluted -0.33-0.74-0.461.41-0.58-0.57-0.64-2.44-0.22-0.23-0.351.280.18-0.010.622.21-0.03-0.29-0.010.020.00-0.090.030.210.06-0.47-0.52-0.59-0.300.29NA-0.140.25-0.23-0.10-0.27NANANANA-0.03-0.37-0.01-0.24-0.20-0.27-0.18-0.20-0.14-0.13-0.25-0.10

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Revenue From Contract With Customer Excluding Assessed Tax 159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30118.31112.27115.80160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Revenues 159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30120.91104.15110.30160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Realized Investment Gains Losses -0.17-0.060.010.160.060.860.015.82NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Gain Loss On Investments 2.35-6.34-6.625.224.010.860.015.820.839.620.25NANA0.00NANANANANANANANANANANANANANANA0.00NA0.000.580.54-0.260.400.300.170.841.061.450.000.000.024.450.020.03-0.320.45-0.01-0.14-1.01
Cost Of Goods And Services Sold 1.514.754.172.233.082.962.583.303.093.012.551.010.971.361.041.820.000.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Costs And Expenses 218.92219.31199.42219.40218.94198.72203.58312.94196.62197.29194.49233.03165.37182.64175.68181.33163.97168.03147.72NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Selling General And Administrative Expense 34.4233.8034.1337.6031.0956.4561.20138.8768.4572.0274.9983.2860.0475.1168.2266.0668.7166.2043.6545.7126.7922.3213.6818.0410.199.8210.56NANANANANANANANANANANANANANANANANANANANANANANANANA
Operating Income Loss -59.15-85.51-57.50220.60-85.85-72.97-91.97-22.66-36.54-51.75-61.13260.652.52-18.83121.5310.78-18.57-50.28-3.30-1.6913.91-1.6713.9941.1616.11-48.93-54.65-62.94-48.1444.65NA-9.3310.08-21.49-6.65-29.67-19.86-25.50-7.931.62-26.12-28.053.70-18.45-18.62-22.32-14.06-16.11-15.86-8.95-18.67-4.88
Interest Expense 2.142.132.122.242.342.362.4111.5111.3211.1710.9913.3612.0011.8011.6011.4611.2811.1110.9410.7910.8211.7811.369.939.759.629.499.359.239.13NA9.027.315.004.964.944.884.874.814.794.825.945.225.185.114.773.443.423.403.343.263.24
Interest Paid Net 0.660.950.591.250.662.270.592.550.612.490.604.400.704.110.674.160.684.110.644.010.413.500.113.020.88NANANANANANANANANANANANANANANANANANANANANA0.122.27NANA0.132.28
Allocated Share Based Compensation Expense 23.8424.5026.2422.2630.5430.0237.8695.0445.8448.4440.7935.0124.1341.9345.5134.1034.8833.8828.4522.3321.4721.2620.9115.1617.5919.2620.1017.4115.0013.61NA13.308.498.127.717.073.102.812.642.871.812.032.462.272.252.362.502.732.712.963.13NA
Income Tax Expense Benefit 0.282.261.090.30-1.310.330.13317.782.65-0.44-3.2634.30-14.91-6.9331.05-291.960.450.360.01-7.160.960.220.002.930.00-0.230.230.370.000.79NA-0.79-15.411.400.88-2.28NANANANA-8.40-0.710.000.000.000.000.010.000.090.000.00NA
Income Taxes Paid 0.000.000.000.04NANA0.002.3223.480.050.000.009.040.000.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Net Income Loss -46.99-105.14-65.17224.61-82.47-80.88-89.87-340.27-30.94-31.84-48.23184.4126.16-0.8884.44320.08-4.56-40.36-1.422.74-0.98-11.213.4725.867.35-56.85-62.92-71.43-35.7835.65NA-16.7231.05-26.68-12.08-31.28NANANANANANANANANANA-17.89-19.99NANA-25.15-9.66
Comprehensive Income Net Of Tax -56.12-110.56-81.08219.38-84.11-82.47-93.00-341.77-34.08-21.05-50.17184.5025.042.4888.85320.57-4.46-39.74-2.861.28-0.71-11.123.3522.007.71-67.59-65.47-67.04-72.146.95NA-9.3553.91-34.50-16.36-23.36-32.22-22.54-0.923.639.00-37.760.00-23.47-19.65-28.43NANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Assets 2421.972456.132519.092611.692414.892497.072248.552389.763095.703078.953090.913233.112894.992877.762835.892667.782247.912247.321299.561322.021252.561090.831084.00912.47843.59811.11875.82956.11988.00976.26NA955.43955.81793.80817.78834.62847.16881.92788.65552.96545.69485.68472.39470.81484.89505.79529.57505.94550.48NANANA
Liabilities 1827.611831.411809.521839.951884.361914.391567.991546.411489.321484.151520.501548.571397.021420.561448.471480.621407.771429.88912.46903.30854.89875.26882.19812.90703.95699.90717.66755.32742.59675.94NA679.58698.03449.03450.92460.51468.77480.47387.57351.87362.92315.40318.08319.94313.46318.96317.36278.24305.94NANANA
Liabilities And Stockholders Equity 2421.972456.132519.092611.692414.892497.072248.552389.763095.703078.953090.913233.112894.992877.762835.892667.782247.912247.321299.561322.021252.561090.831084.00912.47843.59811.11875.82956.11988.00976.26NA955.43955.81793.80817.78834.62847.16881.92788.65552.96545.69485.68472.39470.81484.89505.79529.57505.94550.48NANANA
Stockholders Equity 594.36624.73709.57771.74530.54582.67680.56843.351383.151377.171360.241471.091336.291269.381207.651048.08710.55696.25301.39330.87307.97215.57201.8199.56139.64111.21158.16200.79245.41300.32NA275.85257.78344.77366.86374.10378.39401.45401.08201.09182.77170.28154.31150.87171.43186.82NANA244.54NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Assets Current 2152.132191.152253.122345.052155.742238.421989.422130.712536.982531.192558.052720.602408.092414.222373.952207.892079.222083.271143.281167.981111.11964.36962.37797.93730.33697.97763.91837.00868.26855.45NA835.43836.60681.16705.80722.05735.51763.30669.06431.83423.44361.59350.42347.61360.14377.09410.72437.39483.14NANANA
Cash And Cash Equivalents At Carrying Value 314.99521.92542.51869.19632.95565.12414.15397.66633.06530.18486.19683.29247.94272.52375.81278.82479.89805.49227.50129.63159.18132.99114.2284.6984.28112.5393.34128.80126.59119.49NA148.35143.0073.2294.08161.78159.97256.41296.54107.65124.4884.5685.6456.3965.4855.2685.0286.2070.05100.1246.0498.59
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 314.99521.92542.51869.19632.95565.12414.15397.66633.06530.18486.19683.29247.94272.52375.81278.82479.89805.49227.50129.63NANANA84.69NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Short Term Investments 1666.671499.91NA1245.78NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Net 20.6419.8124.0324.8122.9324.1022.2021.9622.1723.7222.8918.1819.3818.5011.068.588.38NANA9.98NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Inventory Finished Goods 0.290.310.470.390.611.561.913.000.950.740.600.26NANANA0.09NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Current 143.17142.76150.58143.37136.64131.04123.83140.16146.63131.01122.47139.84118.81102.0798.69102.4797.1276.9962.0672.3348.9351.5325.9314.7615.2417.2517.4014.7729.0729.87NA13.1515.698.358.579.817.527.375.798.078.737.805.727.425.427.557.617.387.06NANANA
Equity Securities Fv Ni 47.6345.11NA50.53NANANANANANANANA0.610.900.971.35NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Available For Sale Securities Debt Securities 1701.031523.27NA1248.12NANANANANANANANANANANANANANANANANANANANANANANA657.94NANANANA605.91NANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Amortization Of Intangible Assets 0.610.600.590.610.600.590.540.540.530.510.490.770.190.480.470.470.460.450.44NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Property Plant And Equipment Net 180.81177.01177.72178.07180.14179.32180.41181.08181.52172.62163.95153.65148.72135.35133.52132.16132.00127.94123.19121.91116.6299.6895.4492.8490.9790.6090.3690.2389.2489.69NA89.0588.9688.0786.3286.6486.2087.2788.3189.6991.0892.6094.0195.1396.6198.0288.0137.6835.70NANANA
Finite Lived Intangible Assets Net 29.6129.0529.3029.0030.0429.3728.8027.9428.2727.7026.7525.6726.9826.0625.2224.0324.0323.4522.9122.00NANANA20.36NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Assets Noncurrent 59.4358.9258.9559.5748.9749.9649.9250.0341.1941.4732.5527.6326.2025.7825.9512.9112.6612.6510.1810.132.925.43NA1.32NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Equity Securities Fv Ni 47.6345.11NA50.53NANANANANANANANA0.610.900.971.35NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Liabilities Current 283.45267.81228.45240.55279.78293.82295.11583.25244.57231.34258.02273.00231.78241.21252.47280.29260.24248.62212.64224.74177.65191.76170.58133.78106.89111.08124.50148.88122.20102.13NA100.29115.33107.33100.82100.8497.81103.2887.0070.3074.3251.6055.0661.7176.1183.5491.9894.40105.89NANANA
Accounts Payable Current 20.5510.3516.1211.908.3614.669.5117.2016.227.4121.1716.0713.1515.6313.3328.6613.5813.2913.8324.8923.5213.2723.2421.1215.6817.5819.4628.3619.2910.95NA16.4917.9815.6313.459.8711.018.789.465.3810.245.266.195.348.306.653.074.656.52NANANA
Other Accrued Liabilities Current 13.05NANA12.31NANANA30.86NANANA32.02NANANA13.94NANANA16.48NANANA6.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accrued Income Taxes Current 0.020.010.900.040.451.881.331.328.9327.9432.9532.511.954.0418.400.86NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Accrued Liabilities Current 128.00134.3499.2688.5675.6875.1578.7790.1680.7567.8062.5166.7752.6249.6845.1348.3650.7958.4966.4766.6233.9635.8830.8736.0123.6218.9826.1728.1124.4923.75NA23.7530.4529.1425.1727.9022.0922.2816.5117.7615.4011.9015.6215.6018.6615.0710.878.1312.39NANANA
Contract With Customer Liability Current 99.5193.3991.4497.7197.92102.07106.74108.38104.43100.40120.81118.27137.61137.39144.85160.26157.15160.59120.13125.34NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Stockholders Equity 594.36624.73709.57771.74530.54582.67680.56843.351383.151377.171360.241471.091336.291269.381207.651048.08710.55696.25301.39330.87307.97215.57201.8199.56139.64111.21158.16200.79245.41300.32NA275.85257.78344.77366.86374.10378.39401.45401.08201.09182.77170.28154.31150.87171.43186.82NANA244.54NANANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 594.36624.73709.57771.74530.54582.67680.56843.351606.381594.801570.411684.551497.971457.201387.421187.16840.14817.44387.10418.72397.67NANA99.56NANANA200.79NANANANA257.78NANANA378.39NANANA182.77NANANA171.43NA212.22227.70244.54NANANA
Common Stock Value 0.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.140.120.120.120.120.120.120.120.120.120.120.120.12NA0.120.120.120.120.120.120.120.110.100.100.100.100.100.100.100.100.100.10NANANA
Additional Paid In Capital Common Stock 2034.552008.791983.081964.171942.351910.381925.802113.652311.682271.632233.642203.782219.092177.222117.972047.252030.312011.561576.951549.901528.191434.991410.101311.231373.311352.591331.941309.111286.691269.45NA1251.931224.511365.411352.991343.871324.801315.641292.741091.841077.151073.661019.941016.501013.591009.331006.291003.601000.18NANANA
Retained Earnings Accumulated Deficit -1377.19-1330.20-1225.07-1159.90-1384.52-1302.05-1221.17-1249.37-909.10-878.15-846.31-707.53-857.56-883.73-882.85-967.29-1287.37-1282.81-1242.45-1187.40-1190.14-1189.17-1177.96-1181.43-1207.29-1214.64-1157.79-1094.87-1023.44-987.66NA-1023.31-1006.59-1037.65-1010.97-998.89-967.61-943.33-918.76-908.64-906.97-904.33-866.69-865.48-841.49-821.45-794.57-776.68-756.69NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -63.14-54.01-48.58-32.67-27.44-25.80-24.20-21.07-19.57-16.44-27.23-25.29-25.38-24.25-27.61-32.02-32.53-32.63-33.23-31.76-30.20-30.37-30.46-30.36-26.50-26.85-16.11-13.56-17.9618.41NA47.1139.7516.8924.7229.0021.0829.0226.9917.7812.480.850.97-0.24-0.77-1.150.400.690.95NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 23.8424.5026.2422.2630.5430.0237.8695.0445.8448.4440.7935.0124.1341.9345.5134.1034.8833.8828.45NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Operating Activities -24.43-18.10-31.65203.69-55.57-62.65-54.6697.98-10.36-44.14-7.58277.93-12.81-27.11107.70115.49-26.00500.2413.1620.4028.722.36122.67-26.8424.29NANANANANANANANANANANANANANANANA-24.87-2.58-6.71-24.33-24.45-26.18-39.84-25.50-21.435.03-21.69
Net Cash Provided By Used In Investing Activities -183.93-3.30-287.5595.11121.97-101.0378.86187.85101.9479.69-95.01138.191.40-110.69-70.17-326.21-307.67-375.1779.49-54.21-150.1014.70-168.6820.80-57.09NANANANANANANANANANANANANANANANA-10.6124.09-0.5233.96-4.4224.6456.72-7.2475.91-59.9414.96
Net Cash Provided By Used In Financing Activities 1.831.22-7.33-62.491.46314.54-7.58-521.4810.948.44-94.5019.23-13.1734.5159.469.658.08452.925.224.26147.571.7175.556.454.54NANANANANANANANANANANANANANANANA34.407.74-1.850.58-0.890.36-0.732.67-0.402.350.07

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Operating Activities -24.43-18.10-31.65203.69-55.57-62.65-54.6697.98-10.36-44.14-7.58277.93-12.81-27.11107.70115.49-26.00500.2413.1620.4028.722.36122.67-26.8424.29NANANANANANANANANANANANANANANANA-24.87-2.58-6.71-24.33-24.45-26.18-39.84-25.50-21.435.03-21.69
Net Income Loss -46.99-105.14-65.17224.61-82.47-80.88-89.87-340.27-30.94-31.84-48.23184.4126.16-0.8884.44320.08-4.56-40.36-1.422.74-0.98-11.213.4725.867.35-56.85-62.92-71.43-35.7835.65NA-16.7231.05-26.68-12.08-31.28NANANANANANANANANANA-17.89-19.99NANA-25.15-9.66
Increase Decrease In Inventories 0.83-4.22-0.771.88-1.171.900.23-0.21-1.550.842.18-1.200.873.262.480.20-0.690.01-0.921.531.95-0.30-0.69-1.831.651.15-0.380.32-0.20-0.06NA0.55-0.80-0.690.24-0.500.65-0.922.50-0.31NANANANANANANANANANANANA
Increase Decrease In Accounts Payable 8.28-5.552.884.74-7.926.75-9.578.213.97-15.350.412.42-2.661.09-17.1912.950.63-1.09-13.143.498.32-10.500.474.52-2.76-1.02-11.428.359.06-5.50NA-2.693.41-0.584.64-2.652.36-0.463.74-5.57NANANANANANANANANANANANA
Share Based Compensation 23.8424.5026.2422.2630.5430.0237.8695.0445.8448.4440.7935.0124.1341.9345.5134.1034.8833.8828.4522.3321.4721.2620.9115.1617.5919.2620.1017.4115.0013.61NA13.308.498.127.717.073.102.812.642.87NANANANANANANANANANANANA
Amortization Of Financing Costs 1.351.341.341.371.391.330.860.690.650.640.590.490.490.480.470.470.490.410.440.410.410.400.400.320.310.300.300.290.290.28NA0.280.180.140.140.140.110.110.100.10NANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Investing Activities -183.93-3.30-287.5595.11121.97-101.0378.86187.85101.9479.69-95.01138.191.40-110.69-70.17-326.21-307.67-375.1779.49-54.21-150.1014.70-168.6820.80-57.09NANANANANANANANANANANANANANANANA-10.6124.09-0.5233.96-4.4224.6456.72-7.2475.91-59.9414.96
Payments To Acquire Property Plant And Equipment 5.543.332.712.503.324.361.775.1511.799.109.087.7615.904.013.231.393.246.632.348.2617.056.223.242.791.052.630.632.411.343.06NA0.883.550.871.701.400.440.520.370.220.450.170.750.11-0.321.673.412.580.500.850.8911.01

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Net Cash Provided By Used In Financing Activities 1.831.22-7.33-62.491.46314.54-7.58-521.4810.948.44-94.5019.23-13.1734.5159.469.658.08452.925.224.26147.571.7175.556.454.54NANANANANANANANANANANANANANANANA34.407.74-1.850.58-0.890.36-0.732.67-0.402.350.07

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-05-31 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31
Revenues 159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30120.91104.15110.30160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Revenue From Contract With Customer Excluding Assessed Tax 159.77133.79141.92440.01133.09125.75111.61290.28160.08145.54133.37493.68167.89163.81297.21192.11145.40117.75144.42172.30118.31112.27115.80160.35110.9338.4736.8751.5749.12120.4391.2062.5884.8644.0657.0828.1642.2523.5938.0943.3619.8711.6047.3423.2332.4020.7124.8221.1526.4228.6223.5029.93
Collaborative Agreement Revenue 69.2538.2549.78NA48.2739.8927.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Commercial 72.4178.1872.2887.2784.8285.8684.4595.6695.3489.7383.96100.3695.7088.3068.0972.9582.7657.2042.0253.9134.6223.697.80NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Eplontersen Joint Development Revenue 18.1117.3619.85NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ion859 NANA10.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Licensing And Other Royalties 4.848.1712.319.622.732.154.621.572.131.622.795.572.087.931.620.5212.750.550.941.831.731.322.59NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue 87.3655.6169.63NA48.2739.8927.16NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Spinraza Royalties 61.6559.6353.8269.0566.5772.1759.9974.6674.1771.7566.0181.1181.6770.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product 5.9210.396.168.6015.5211.5419.8419.4419.0416.3615.1613.6911.959.876.752.240.00NA0.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Ion859, Biogen Collaboration2013 Strategic Neurology NANA10.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue, Biogen Collaborations 27.4017.3040.10NA17.4027.8018.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Revenue, Roche Collaborations 41.50NANANA3.90NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Spinraza Royalties, Biogen Collaborations 61.6059.6053.8069.1066.6072.2060.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Subsequent Event, Biogen Collaboration2013 Strategic Neurology NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Subsequent Event, Roche Collaboration Ionis Fb L For Complement Mediated Diseases NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Biogen Collaboration2013 Strategic Neurology NANA18.00NANANANANANANANANA-16.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Biogen Collaborations 89.0076.9093.90166.7084.00100.0078.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Biogen Collaborations2013 Strategic Neurology And2012 Neurology 13.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Roche Collaboration Ionis Fb L For Complement Mediated Diseases 35.0013.80NANANANANA-9.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Roche Collaborations NA19.50NANANA3.60NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Income Tax Expense Benefit
Balance Sheet
Finite Lived Intangible Assets Net
Assets
Inventory Net
Current Assets
Inventory Net
NonCurrent Assets
Finite Lived Intangible Assets Net
Liabilities
Liabilities Current
Current Liabilities
Accrued Income Taxes Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Diluted Shares Outstanding
InventoryNet
Inventory Finished Goods

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('ions:ResearchAndDevelopmentRevenue', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:EquitySecuritiesFvNi
us-gaap:FinancialInstrument
(None,)
Equity Securities Fv Nius-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:FairValueByMeasurementFrequency
(None, 'us-gaap:FairValueMeasurementsRecurring')
Equity Securities Fv Nius-gaap: Schedule Of Equity Method Investment Equity Method Investee Name, us-gaap: Fair Value By Measurement Frequency
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel3', 'us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
(None, 'us-gaap:FairValueMeasurementsRecurring', 'ions:EquitySecuritiesPubliclyTradedCompanies')
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:CashAndCashEquivalents', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Balance Sheet Location, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FinancialInstrument
(None,)
Equity Securities Fv Nius-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName, us-gaap:FairValueByMeasurementFrequency
(None, 'us-gaap:FairValueMeasurementsRecurring')
Equity Securities Fv Nius-gaap: Schedule Of Equity Method Investment Equity Method Investee Name, us-gaap: Fair Value By Measurement Frequency
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel3', 'us-gaap:FairValueMeasurementsRecurring', None)
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:EquitySecuritiesFvNi
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
(None, 'us-gaap:FairValueMeasurementsRecurring', 'ions:EquitySecuritiesPubliclyTradedCompanies')
Equity Securities Fv Nius-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('ions:ResearchAndDevelopmentRevenue', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:TypeOfArrangement
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Type Of Arrangement